• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (65)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Cognitive Disorders  • Dementias  • Epilepsy  • Neurogenetics  • Alert me on articles by topic  Social Bookmarking   What's this?

Jorge J. Palop, PhD; Lennart Mucke, MD

Arch Neurol. 2009;66(4):435-440. Published online February 9, 2009 (doi:10.1001/archneurol.2009.15).

Alzheimer disease (AD) is associated with cognitive decline and increased incidence of seizures. Seizure activity in AD has been widely interpreted as a secondary process resulting from advanced stages of neurodegeneration, perhaps in combination with other age-related factors. However, recent findings in animal models of AD have challenged this notion, raising the possibility that aberrant excitatory neuronal activity represents a primary upstream mechanism that may contribute to cognitive deficits in these models. The following observations suggest that such activity may play a similar role in humans with AD: (1) patients with sporadic AD have an increased incidence of seizures that appears to be independent of disease stage and highest in cases with early onset; (2) seizures are part of the natural history of many pedigrees with autosomal dominant early-onset AD, including those with mutations in presenilin-1, presenilin-2, or the amyloid precursor protein, or with duplications of wild-type amyloid precursor protein; (3) inheritance of the major known genetic risk factor for AD, apolipoprotein E4, is associated with subclinical epileptiform activity in carriers without dementia; and (4) some cases of episodic amnestic wandering and disorientation in AD are associated with epileptiform activity and can be prevented with antiepileptic drugs. Here we review recent experimental data demonstrating that high levels of β-amyloid in the brain can cause epileptiform activity and cognitive deficits in transgenic mouse models of AD. We conclude that β-amyloid peptides may contribute to cognitive decline in AD by eliciting similar aberrant neuronal activity in humans and discuss potential clinical and therapeutic implications of this hypothesis.

Author Affiliations: Gladstone Institute of Neurological Disease and Department of Neurology, University of California, San Francisco.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(4):431-432.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study
Thom et al.
Brain 2011;134:2969-2981.
ABSTRACT | FULL TEXT  

Spatial patterns of brain amyloid-{beta} burden and atrophy rate associations in mild cognitive impairment
Tosun et al.
Brain 2011;134:1077-1088.
ABSTRACT | FULL TEXT  

Amyloid-{beta}/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Roberson et al.
J. Neurosci. 2011;31:700-711.
ABSTRACT | FULL TEXT  

Reimagining Alzheimer's Disease--An Age-Based Hypothesis
Herrup
J. Neurosci. 2010;30:16755-16762.
ABSTRACT | FULL TEXT  

Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice
Andrews-Zwilling et al.
J. Neurosci. 2010;30:13707-13717.
ABSTRACT | FULL TEXT  

From the Cover: Spatial correlation between brain aerobic glycolysis and amyloid-{beta} (A{beta}) deposition
Vlassenko et al.
Proc. Natl. Acad. Sci. USA 2010;107:17763-17767.
ABSTRACT | FULL TEXT  

BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Hu et al.
J. Neurosci. 2010;30:8819-8829.
ABSTRACT | FULL TEXT  

Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2
Jayadev et al.
Brain 2010;133:1143-1154.
ABSTRACT | FULL TEXT  

Inhibition of Calcineurin-mediated Endocytosis and {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid {beta} Oligomer-induced Synaptic Disruption
Zhao et al.
J. Biol. Chem. 2010;285:7619-7632.
ABSTRACT | FULL TEXT  

In the Adult Hippocampus, Chronic Nerve Growth Factor Deprivation Shifts GABAergic Signaling from the Hyperpolarizing to the Depolarizing Direction
Lagostena et al.
J. Neurosci. 2010;30:885-893.
ABSTRACT | FULL TEXT  

Many Neuronal and Behavioral Impairments in Transgenic Mouse Models of Alzheimer's Disease Are Independent of Caspase Cleavage of the Amyloid Precursor Protein
Harris et al.
J. Neurosci. 2010;30:372-381.
ABSTRACT | FULL TEXT  

GluN2B subunit-containing NMDA receptor antagonists prevent A{beta}-mediated synaptic plasticity disruption in vivo
Hu et al.
Proc. Natl. Acad. Sci. USA 2009;106:20504-20509.
ABSTRACT | FULL TEXT